3rd Quarter - Report

THE KPM GROUP DC LLC for RARE DISEASE COMPANY COALITION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act

LobbyistCovered position, as disclosed
KATHERINE LANDES —
PATROSKI LAWSON —
AMANDA MALAKOFF —
YOKO ROSENBAUM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7667 (117th), H.R. 5376 (117th), S. 4348 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.